View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 20, 2011

FDA clears PositiveID diabetes management system

PositiveID has received US Food and Drug Administration (FDA) clearance for its iglucose mobile health system for diabetes management.

PositiveID has received US Food and Drug Administration (FDA) clearance for its iglucose mobile health system for diabetes management.

The system collects and transmits stored data from several FDA-cleared blood glucose meters to a secure database using wireless cellular technology.

PositiveID CEO William Caragol said that iglucose is a safe, flexible, convenient, cost-effective and straightforward solution that helps reduce costs to the healthcare system while improving disease management and patient compliance.

The company plans to initiate commercialisation of the device in the first quarter of 2012.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management